3 Biotech companies backed by Omega Funds, including Scorpion Therapeutics, Third Arc Bio, Windward Bio — with the co-investors on each cap table.
Omega Funds — Biotech accounts for 18 tracked companies with verified cap-table data, 18 of which disclose round sizes totalling $3.8B. The median disclosed raise is $197M, and the largest is Alumis at $529M, ahead of Immunic Therapeutics ($400M) and Catalym ($319M).
The names that recur most often on these portfolio cap tables are Omega Funds (18 companies), Cormorant Asset Management (5 companies), Atlas Venture (4 companies), Janus Henderson Investors (4 companies), Jeito Capital (3 companies), Novartis Venture Fund (3 companies). By latest disclosed round, the market skews Series A (8), Series B (6), Series C (2), Growth (1).
Companies tracked: 18
Disclosed funding total: $3.8B across 18 companies
Median disclosed raise: $197M
Largest raise: Alumis — $529M
Stage mix: Series A 8 · Series B 6 · Series C 2 · Growth 1
